*Probiotic Effects on Disease Prevention and Treatment DOI: http://dx.doi.org/10.5772/intechopen.109717*

Mikov M. Probiotic pre-treatment reduces Gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats. Archives of Drug Information. 2008;**1**(1):35-41

[117] Yamano T, Tanida M, Niijima A, Maeda K, Okumura N, Fukushima Y, et al. Effects of the probiotic strain *Lactobacillus johnsonii* strain La1 on autonomic nerves and blood glucose in rats. Life Sciences. 2006;**79**(20):1963-1967

[118] Madempudi RS, Ahire JJ, Neelamraju J, Tripathi A, Nanal S. Efficacy of UB0316, a multistrain probiotic formulation in patients with type 2 diabetes mellitus: A double blind, randomized, placebo controlled study. PLoS One. 2019;**14**(11):e0225168. Available from: https://journals.plos. org/plosone/article?id=10.1371/journal. pone.0225168

[119] Koutnikova H, Genser B, Monteiro-Sepulveda M, Faurie JM, Rizkalla S, Schrezenmeir J, et al. Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: A systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2019;**9**(3):e017995

[120] Wang ZB, Xin SS, Ding LN, Ding WY, Hou YL, Liu CQ, et al. The potential role of probiotics in controlling overweight/obesity and associated metabolic parameters in adults: A systematic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine. 2019;**2019**:1-14

[121] Borgeraas H, Johnson LK, Skattebu J, Hertel JK, Hjelmesaeth J. Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: A systematic review and metaanalysis of randomized controlled trials. Obesity Reviews. 2018;**19**(2):219-232

[122] John GK, Wang L, Nanavati J, Singh R, Mullin G. Mo1963— *Lactobacillus probiotics* reduce body mass index, body weight, and fat mass in overweight and obese subjects: A systematic review and meta-analysis of randomized controlled trials. Gastroenterology. 2018;**154**(6):S-865-S-866

[123] Zhang Q, Wu Y, Fei X. Effect of probiotics on body weight and body-mass index: A systematic review and metaanalysis of randomized, controlled trials. International Journal of Food Sciences and Nutrition. 2016;**67**(5):571-580

[124] Suzumura EA, Bersch-Ferreira ÂC, Torreglosa CR, da Silva JT, Coqueiro AY, Kuntz MGF, et al. Effects of oral supplementation with probiotics or synbiotics in overweight and obese adults: A systematic review and metaanalyses of randomized trials. Nutrition Reviews. 2019;**77**(6):430-450

[125] Park S, Bae JH. Probiotics for weight loss: A systematic review and meta-analysis. Nutrition Research. 2015;**35**(7):566-575

[126] Million M, Angelakis E, Paul M, Armougom F, Leibovici L, Raoult D. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microbial Pathogenesis. 2012;**53**(2):100-108

[127] Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nature Reviews. Gastroenterology & Hepatology. 2012;**9**(10):577

[128] Moreno-Indias I, Cardona F, Tinahones FJ, Queipo-Ortuño MI. Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Frontiers in Microbiology. 2014;**5**:190

[129] Cerdó T, García-Santos JA, G. Bermúdez M, Campoy C. The role of probiotics and prebiotics in the prevention and treatment of obesity. Nutrients. 2019;**11**(3):635

[130] Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, et al. Dietary intervention impact on gut microbial gene richness. Nature. 2013;**500**(7464):585

[131] Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;**500**(7464):541

[132] Kadooka Y, Sato M, Ogawa A, Miyoshi M, Uenishi H, Ogawa H, et al. Effect of *Lactobacillus gasseri* SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. British Journal of Nutrition. 2013;**110**(9):1696-1703

[133] Zarrati M, Shidfar F, Nourijelyani K, Mofid V, Hossein Zadeh-Attar MJ, Bidad K, et al. *Lactobacillus acidophilus* La5, Bifidobacterium BB12, and *Lactobacillus casei* DN001 modulate gene expression of subset specific transcription factors and cytokines in peripheral blood mononuclear cells of obese and overweight people. BioFactors. 2013;**39**(6):633-643

[134] Murugesan S, Nirmalkar K, Hoyo-Vadillo C, García-Espitia M, Ramírez-Sánchez D, García-Mena J. Gut microbiome production of short-chain fatty acids and obesity in children. European Journal of Clinical Microbiology & Infectious Diseases. 2018;**37**(4):621-625

[135] de Clercq NC, Groen AK, Romijn JA, Nieuwdorp M. Gut microbiota in obesity and undernutrition. Advances in Nutrition. 2016;**7**(6):1080-1089

[136] den Besten G, Lange K, Havinga R, van Dijk TH, Gerding A, van Eunen K, et al. Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2013;**305**(12):G900-G910

[137] Liou AP, Paziuk M, Luevano JM Jr, Machineni S, Turnbaugh PJ, Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Science Translational Medicine. 2013;**5**(178):178ra41-178ra41

[138] Perry RJ, Peng L, Barry NA, Cline GW, Zhang D, Cardone RL, et al. Acetate mediates a microbiome–brain–βcell axis to promote metabolic syndrome. Nature. 2016;**534**(7606):213-217

[139] Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, Brody L, et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nature Communications. 2014;**5**:3611

[140] Li Z, Yi CX, Katiraei S, Kooijman S, Zhou E, Chung CK, et al. Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit. Gut. 2018;**67**(7):1269-1279

[141] Den Besten G, Bleeker A, Gerding A, van Eunen K, Havinga R, van Dijk TH, et al. Short-chain fatty acids protect against high-fat diet–induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation. Diabetes. 2015;**64**(7):2398-2408

[142] Lu Y, Fan C, Li P, Lu Y, Chang X, Qi K. Short chain fatty acids prevent

*Probiotic Effects on Disease Prevention and Treatment DOI: http://dx.doi.org/10.5772/intechopen.109717*

high-fat-diet-induced obesity in mice by regulating G protein-coupled receptors and gut microbiota. Scientific Reports. 2016;**6**:37589

[143] Kim KN, Yao Y, Ju SY. Short chain fatty acids and fecal microbiota abundance in humans with obesity: A systematic review and meta-analysis. Nutrients. 2019;**11**(10):2512

[144] Rahat-Rozenbloom S, Fernandes J, Gloor GB, Wolever TMS. Evidence for greater production of colonic shortchain fatty acids in overweight than lean humans. International Journal of Obesity. 2014;**38**(12):1525-1531

[145] Fernandes J, Su W, Rahat-Rozenbloom S, Wolever TMS, Comelli EM. Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutrition & Diabetes. 2014;**4**(6):e121-e121

[146] Riva A, Borgo F, Lassandro C, Verduci E, Morace G, Borghi E, et al. Pediatric obesity is associated with an altered gut microbiota and discordant shifts in F irmicutes populations. Environmental Microbiology. 2017;**19**(1):95-105

[147] Barczyńska R, Litwin M, Sliżewska K, Szalecki M, Berdowska A, Bandurska K, et al. Bacterial microbiota and fatty acids in the faeces of overweight and obese children. Polish Journal of Microbiology. 2018;**67**(3):339-345

[148] Ashaolu TJ. Immune boosting functional foods and their mechanisms: A critical evaluation of probiotics and prebiotics. Biomedicine & Pharmacotherapy. 2020;**130**:110625

[149] Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SEK, et al. Effects of

targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015;**64**(11):1744-1754

[150] Pessione E. Lactic acid bacteria contribution to gut microbiota complexity: Lights and shadows. Frontiers in Cellular and Infection Microbiology. 2012;**2**:86

[151] Brahe LK, Astrup A, Larsen LH. Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases? Obesity Reviews. 2013;**14**(12):950-959

[152] Isolauri E. Microbiota and obesity. Intestinal Microbiome: Functional Aspects in Health and Disease. 2017;**88**:95-106

[153] Kumar A, Wu H, Collier-Hyams LS, Kwon YM, Hanson JM, Neish AS. The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation. The Journal of Immunology. 2009;**182**(1):538-546

[154] Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiology Letters. 2009;**294**(1):1-8

[155] Han MM, Sun JF, Su XH, Peng YF, Goyal H, Wu CH, et al. Probiotics improve glucose and lipid metabolism in pregnant women: A meta-analysis. Annals of Translational Medicine. 2019;**7**(5):99-111

[156] Tabrizi R, Moosazadeh M, Lankarani KB, Akbari M, Heydari ST, Kolahdooz F, et al. The effects of synbiotic supplementation on glucose metabolism and lipid

profiles in patients with diabetes: A systematic review and meta-analysis of randomized controlled trials. Probiotics and Antimicrobial Proteins. 2018;**10**(2):329-342

[157] He J, Zhang F, Han Y. Effect of probiotics on lipid profiles and blood pressure in patients with type 2 diabetes: A meta-analysis of RCTs. Medicine. 2017;**96**(51):e9166

[158] Sahhaf Ebrahimi F, Homayouni Rad A, Mosen M, Abbasalizadeh F, Tabrizi A, Khalili L. Effect of *L. acidophilus* and *B. lactis* on blood glucose in women with gestational diabetes mellitus: A randomized placebocontrolled trial. Diabetology & Metabolic Syndrome. 2019;**11**(1):1-7. Available from: https://dmsjournal. biomedcentral.com/articles/10.1186/ s13098-019-0471-5

[159] Huang R, Wang K, Hu J. Effect of probiotics on depression: A systematic review and meta-analysis of randomized controlled trials. Nutrients. 2016;**8**(8):483

[160] Liu RT, Walsh RFL, Sheehan AE. Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials. Neuroscience and Biobehavioral Reviews. 2019;**102**:13-23

[161] Reis DJ, Ilardi SS, Punt SEW. The anxiolytic effect of probiotics: A systematic review and meta-analysis of the clinical and preclinical literature. PLoS One. 2018;**13**(6):e0199041

[162] Huang R, Ning H, Yang L, Jia C, Yang F, Xu G, et al. Efficacy of probiotics on anxiety: A meta-analysis of randomized controlled trials. Neuropsychiatry. 2017;**07**(06):862-871

[163] Liu B, He Y, Wang M, Liu J, Ju Y, Zhang Y, et al. Efficacy of probiotics on anxiety-a meta-analysis of randomized controlled trials. Depression and Anxiety. 2018;**35**(10):935-945

[164] Zhang N, Liao X, Zhang Y, Li M, Wang W, Zhai S. Probiotic supplements for relieving stress in healthy participants: A protocol for systematic review and meta-analysis of randomized controlled trials. Medicine. 2019;**98**(20):e15416

[165] Nikolova V, Zaidi SY, Young AH, Cleare AJ, Stone JM. Gut feeling: Randomized controlled trials of probiotics for the treatment of clinical depression: Systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology. 2019;**9**:2045125319859963

[166] Ng QX, Peters C, Ho CYX, Lim DY, Yeo WS. A meta-analysis of the use of probiotics to alleviate depressive symptoms. Journal of Affective Disorders. 2018;**228**:13-19

[167] Rahimlou M, Hosseini SA, Majdinasab N, Haghighizadeh MH, Husain D. Effects of long-term administration of multi-strain probiotic on circulating levels of BDNF, NGF, IL-6 and mental health in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Nutritional Neuroscience. 2020;**25**(2):411-422. DOI: 101080/1028415X20201758887. Available from: https://www. tandfonline.com/doi/abs/10.1080/10284 15X.2020.1758887

[168] Wallace CJK, Milev R. The effects of probiotics on depressive symptoms in humans: A systematic review. Annals of General Psychiatry. 2017;**16**(1):14

[169] Miller AH, Maletic V, Raison CL. Inflammation and its discontents: The role of cytokines in the pathophysiology *Probiotic Effects on Disease Prevention and Treatment DOI: http://dx.doi.org/10.5772/intechopen.109717*

of major depression. Biological Psychiatry. 2009;**65**(9):732-741

[170] Anisman H, Merali Z, Hayley S. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders. Progress in Neurobiology. 2008;**85**(1):1-74

[171] Dunn AJ. Effects of cytokines and infections on brain neurochemistry. Clinical Neuroscience Research. 2006;**6**(1-2):52-68

[172] Paterson LM, Nutt DJ, Wilson SJ. NAPSAQ-1: National Patient Sleep Assessment Questionnaire in depression. International Journal of Psychiatry in Clinical Practice. 2009;**13**(1):48-58

[173] Jackson ML, Butt H, Ball M, Lewis DP, Bruck D. Sleep quality and the treatment of intestinal microbiota imbalance in chronic fatigue syndrome: A pilot study. Sleep Science. 2015;**8**(3):124-133

[174] McEwen BS. Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiological Reviews. 2007;**87**(3):873-904

[175] Luo J, Wang T, Liang S, Hu X, Li W, Jin F. Ingestion of Lactobacillus strain reduces anxiety and improves cognitive function in the hyperammonemia rat. Science China. Life Sciences. 2014;**57**(3):327-335

[176] Ait-Belgnaoui A, Durand H, Cartier C, Chaumaz G, Eutamene H, Ferrier L, et al. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology. 2012;**37**(11):1885-1895
